Phase I–II trial evaluating combined intensity-modulated radiotherapy and in situ gene therapy with or without hormonal therapy in treatment of prostate cancer—interim report on PSA response and biopsy data-Reference-Cited by-同舟云学术

Phase I–II trial evaluating combined intensity-modulated radiotherapy and in situ gene therapy with or without hormonal therapy in treatment of prostate cancer—interim report on PSA response and biopsy data

Published:2004-04 Issue:5 Volume:58 Page:1520-1529
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Teh Bin S,Ayala Gustavo,Aguilar Laura,Mai Wei-Yuan,Timme Terry L,Vlachaki Maria T,Miles Brian,Kadmon Dov,Wheeler Thomas,Caillouet James,Davis Maria,Carpenter L.Steven,Lu Hsin H,Chiu J.Kam,Woo Shiao Y,Thompson Timothy,Aguilar-Cordova Estuardo,Butler E.Brian

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,Radiation

Reference47 articles.

1. Cancer statistics, 2003;Jemal;CA Cancer J Clin,2003

2. Patterns of care studies;Hanks;Int J Radiat Oncol Biol Phys,1985

3. External beam radiotherapy dose response of prostate cancer;Pollack;Int J Radiat Oncol Biol Phys,1997

4. The effect of dose on local control of prostate cancer;Hanks;Int J Radiat Oncol Biol Phys,1988

5. Conformal technique dose escalation for prostate cancer;Hanks;Int J Radiat Oncol Biol Phys,1996

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Phase 2 Trial of Enhancing Immune Checkpoint Blockade by Stereotactic Radiation and In Situ Virus Gene Therapy in Metastatic Triple-Negative Breast Cancer;Clinical Cancer Research;2022-07-25

2. Solitary Leptomeningeal Recurrence From Prostate Adenocarcinoma After Treatment With Cytotoxic Gene Therapy, Radiation Therapy, and Androgen Deprivation Therapy;Advances in Radiation Oncology;2021-07

3. Immunotherapy in prostate cancer: current state and future perspectives;Therapeutic Advances in Urology;2020-01

4. Phase I study of gene-mediated cytotoxic immunotherapy with AdV-tk as adjuvant to surgery and radiation for pediatric malignant glioma and recurrent ependymoma;Neuro-Oncology;2019-03-18

5. Phase I Study of Intrapleural Gene-Mediated Cytotoxic Immunotherapy in Patients with Malignant Pleural Effusion;Molecular Therapy;2018-05